Page last updated: 2024-10-30

losartan and Seizures

losartan has been researched along with Seizures in 11 studies

Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position

Seizures: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or seizure disorder.

Research Excerpts

ExcerptRelevanceReference
"The use of losartan with sodium valproate in epilepsy may prevent the cognitive and cardiac sequelae of seizures."7.91Effects of enalapril and losartan alone and in combination with sodium valproate on seizures, memory, and cardiac changes in rats. ( Arava, S; Gupta, YK; Joshi, D; Katyal, J, 2019)
"Spontaneous seizures were video- and EEG-monitored in spontaneously hypertensive rats (SHRs) for a 16-week period after SE."5.43Long-Term Treatment with Losartan Attenuates Seizure Activity and Neuronal Damage Without Affecting Behavioral Changes in a Model of Co-morbid Hypertension and Epilepsy. ( Atanasova, D; Ivanova, N; Kortenska, L; Lazarov, N; Lozanov, V; Mitreva, R; Pechlivanova, DM; Stoynev, A; Tchekalarova, JD, 2016)
"The use of losartan with sodium valproate in epilepsy may prevent the cognitive and cardiac sequelae of seizures."3.91Effects of enalapril and losartan alone and in combination with sodium valproate on seizures, memory, and cardiac changes in rats. ( Arava, S; Gupta, YK; Joshi, D; Katyal, J, 2019)
" The aim of the current study was to evaluate the effects of losartan (2-n-butyl-4-chloro-5-hydroxymethyl-1-[(2'(1H-tetrazol-5-yl)-biphenil-4-yl)methyl]imidazole) and telmisartan (49-[(1,49-dimethyl-29-propyl[2,69-bi-1H-benzimidazo]-19-yl)methyl]-[1,19-biphenyl]-2-carboxylic acid), the angiotensin AT1 receptor antagonists which are widely used in clinical practice, on the protective action of conventional antiepileptic drugs (carbamazepine, phenytoin, valproate and phenobarbital) against maximal electroshock-induced seizures in mice."3.76Angiotensin AT1 receptor antagonists enhance the anticonvulsant action of valproate in the mouse model of maximal electroshock. ( Czuczwar, SJ; Jakubus, T; Janowska, A; Tochman-Gawda, A; Łukawski, K, 2010)
"The effects of non-peptide AT1- and AT2-receptor antagonists DuP 753 (losartan) and PD 123319 on the intensity of pentylenetetrazol (PTZ)-kindled seizures in mice were studied."3.69Effects of non-peptide angiotensin II-receptor antagonists on pentylenetetrazol kindling in mice. ( Georgiev, VP; Kambourova, TS; Lazarova, MB, 1996)
"In this review, we intended to highlight the role of drug-drug interactions involving angiotensin II receptor antagonists with antiepileptic drugs accompanied by a brief characteristic of the role of RAS in neuroinflammation."2.66A review of clinically significant drug-drug interactions involving angiotensin II receptor antagonists and antiepileptic drugs. ( Czuczwar, SJ; Rusek, M, 2020)
"Spontaneous seizures were video- and EEG-monitored in spontaneously hypertensive rats (SHRs) for a 16-week period after SE."1.43Long-Term Treatment with Losartan Attenuates Seizure Activity and Neuronal Damage Without Affecting Behavioral Changes in a Model of Co-morbid Hypertension and Epilepsy. ( Atanasova, D; Ivanova, N; Kortenska, L; Lazarov, N; Lozanov, V; Mitreva, R; Pechlivanova, DM; Stoynev, A; Tchekalarova, JD, 2016)
"Prazosin potentiated the anti-seizure effect of Ang III against MTW, GNCL, and THE in non-stressed mice while it reversed the seizure threshold-decreasing effect of this heptapeptide on MTW and GNCL in stressed mice."1.33Ang II and Ang III modulate PTZ seizure threshold in non-stressed and stressed mice: possible involvement of noradrenergic mechanism. ( Georgiev, V; Tchekalarova, J, 2006)

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (18.18)18.2507
2000's2 (18.18)29.6817
2010's6 (54.55)24.3611
2020's1 (9.09)2.80

Authors

AuthorsStudies
Rusek, M1
Czuczwar, SJ3
Joshi, D1
Katyal, J1
Arava, S1
Gupta, YK1
Hong, S1
JianCheng, H1
JiaWen, W1
ShuQin, Z1
GuiLian, Z1
HaiQin, W1
Ru, Z1
Zhen, G1
HongWei, R1
Lukawski, K1
Janowska, A2
Jakubus, T2
Raszewski, G1
Tchekalarova, J3
Ivanova, N2
Pechlivanova, D2
Ilieva, K1
Atanasova, M1
Tchekalarova, JD1
Atanasova, D1
Pechlivanova, DM1
Lazarov, N1
Kortenska, L1
Mitreva, R1
Lozanov, V1
Stoynev, A1
Łukawski, K1
Tochman-Gawda, A1
Kambourova, T1
Matsoukas, J1
Georgiev, V3
Georgiev, VP1
Lazarova, MB1
Kambourova, TS1
Opitz, M1

Reviews

1 review available for losartan and Seizures

ArticleYear
A review of clinically significant drug-drug interactions involving angiotensin II receptor antagonists and antiepileptic drugs.
    Expert opinion on drug metabolism & toxicology, 2020, Volume: 16, Issue:6

    Topics: Angiotensin Receptor Antagonists; Animals; Anticonvulsants; Drug Interactions; Humans; Losartan; Neu

2020

Other Studies

10 other studies available for losartan and Seizures

ArticleYear
Effects of enalapril and losartan alone and in combination with sodium valproate on seizures, memory, and cardiac changes in rats.
    Epilepsy & behavior : E&B, 2019, Volume: 92

    Topics: Animals; Anticonvulsants; Drug Therapy, Combination; Enalapril; Heart Diseases; Kindling, Neurologic

2019
Losartan inhibits development of spontaneous recurrent seizures by preventing astrocyte activation and attenuating blood-brain barrier permeability following pilocarpine-induced status epilepticus.
    Brain research bulletin, 2019, Volume: 149

    Topics: Animals; Astrocytes; Blood-Brain Barrier; Brain; Disease Models, Animal; Epilepsy; Losartan; Male; N

2019
Combined treatment with gabapentin and drugs affecting the renin-angiotensin system against electroconvulsions in mice.
    European journal of pharmacology, 2013, Apr-15, Volume: 706, Issue:1-3

    Topics: Amines; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals;

2013
Strain-dependent effects of sub-chronically infused losartan against kainic acid-induced seizures, oxidative stress, and heat shock protein 72 expression.
    Cellular and molecular neurobiology, 2014, Volume: 34, Issue:1

    Topics: Animals; Cerebral Cortex; Cytosol; Hippocampus; HSP72 Heat-Shock Proteins; Infusions, Subcutaneous;

2014
Long-Term Treatment with Losartan Attenuates Seizure Activity and Neuronal Damage Without Affecting Behavioral Changes in a Model of Co-morbid Hypertension and Epilepsy.
    Cellular and molecular neurobiology, 2016, Volume: 36, Issue:6

    Topics: Animals; Behavior, Animal; Disease Models, Animal; Hippocampus; Hypertension; Losartan; Male; Neuron

2016
Angiotensin AT1 receptor antagonists enhance the anticonvulsant action of valproate in the mouse model of maximal electroshock.
    European journal of pharmacology, 2010, Aug-25, Volume: 640, Issue:1-3

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Anticonvulsants; Behavior, Animal; Benzimidazoles;

2010
The effects of sarmesin, an Angiotensin II analogue on seizure susceptibility, memory retention and nociception.
    Regulatory peptides, 2003, Mar-28, Volume: 111, Issue:1-3

    Topics: Angiotensin II; Animals; Avoidance Learning; Disease Models, Animal; Drug Combinations; Imidazoles;

2003
Ang II and Ang III modulate PTZ seizure threshold in non-stressed and stressed mice: possible involvement of noradrenergic mechanism.
    Neuropeptides, 2006, Volume: 40, Issue:5

    Topics: Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibitors; Angiotensin II; Angiotensin II Type 1 Re

2006
Effects of non-peptide angiotensin II-receptor antagonists on pentylenetetrazol kindling in mice.
    Neuropeptides, 1996, Volume: 30, Issue:5

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Anticonvulsants; Biphenyl Compounds; Conv

1996
Participation of angiotensin receptors in acute hypoxia in mice. II. Effects of angiotensin II nonpeptide receptor ligands losartan (DuP-753) and PD-123319.
    Methods and findings in experimental and clinical pharmacology, 1999, Volume: 21, Issue:7

    Topics: Acute Disease; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; D

1999